As the world grapples with Covid-19, antibiotics used to treat serious secondary bacterial infections associated with the coronavirus are making their way into wastewater with potentially dire consequences.
Most concerning is the fact that some output from wastewater treatment plants includes traces of antibiotic-resistant DNA. This genetic material is potentially dangerous, as it may not be possible to halt host organisms with common antibiotics. Covid-19 is a virus, so antibiotics will not treat it. However, infected patients in intensive care frequently develop respiratory bacterial infections, particularly those treated on ventilators. 'Covid is not going away': Virologist fund manager Dr Ogden on coronavirus, healthcare valuations and biotech opportunities If the clinician is ...
To continue reading this article...
Join Investment Week for free
Signup and gain exclusive members-only insights - all free of charge!
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes
